Bristol Myers Squibb buys Nvidia AI system for drug discovery
Bristol Myers Squibb is buying an Nvidia DGX SuperPOD constructed on the chipmaker’s Vera Rubin structure to help synthetic intelligence use throughout its drug discovery and improvement operations. The pharmaceutical firm stated it will likely be the primary life sciences group to accumulate a DGX SuperPOD primarily based on Vera Rubin. Nvidia launched the structure…
